Literature DB >> 12540523

The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions.

Stephen G Howitt1, Kalle Kilk, Yang Wang, David M Smith, Ulo Langel, David R Poyner.   

Abstract

1. The role of individual residues in the 8-18 helix of CGRP(8-37) in promoting high-affinity binding to CGRP(1) receptors expressed on rat L6 and human SK-N-MC cells has been examined. The relative potencies of various derivatives were estimated from their ability to inhibit the human alphaCGRP-mediated increase in cyclic AMP production and the binding of [(125)I]-human alphaCGRP. 2. Arg(11) and Arg(18) were replaced by serines to give [Ser(11,18)]CGRP(8-37). These bound with pKi values <6 to SK-N-MC cells and had apparent pA(2) values of 5.81+/-0.04 and 5.31+/-0.11 on SK-N-MC and L6 cells. CGRP(8-37) had a pKi of 8.22 on SK-N-MC cells and pK(b) values on the above cell lines of 8.95+/-0.04 and 8.76+/-0.04. 3. The arginines were replaced with glutamic acid residues. [Glu(11)]CGRP(8-37) had a pK(b) of 7.14+/-0.14 on SK-N-MC cells (pKi=7.05+/-0.05) and 6.99+/-0.08 on L6 cells. [Glu(18)]CGRP(8-37) had a pK(b) of 7.10+/-0.0.08 on SK-N-MC cells (pKi=6.91+/-0.23) and 7.12+/-0.09 on L6 cells. 4. Leu(12), Leu(15) and Leu(16) were replaced by benzoyl-phenylalanine (bpa) residues. On SK-N-MC cells, the apparent pA(2) values of [bpa(12)]-, [bpa(15)]- and [bpa(16)]CGRP(8-37) were respectively 7.43+/-0.23, 8.34+/-0.11 and 5.66+/-0.16 (pKi values of 7.14+/-0.17, 7.66+/-0.21 and <6): on L6 cells they were 7.96+/-0.36, 8.28+/-0.21 and 6.09+/-0.04 (all n=3). 5. It is concluded that the Arg(11) and Arg(18) are involved in specific electrostatic interactions with other residues, either on the CGRP(1) receptors or elsewhere on CGRP(8-37). Leu(16) is in a conformationally restricted site when CGRP(8-37) binds to CGRP(1) receptors, unlike Leu(12) and Leu(15).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540523      PMCID: PMC1573669          DOI: 10.1038/sj.bjp.0705040

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.

Authors:  David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

2.  Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.

Authors:  John J Mallee; Christopher A Salvatore; Beatrice LeBourdelles; Kevin R Oliver; Jenny Longmore; Kenneth S Koblan; Stefanie A Kane
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

3.  Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens.

Authors:  F M Wisskirchen; P M Doyle; S L Gough; C J Harris; I Marshall
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells.

Authors:  F Van Valen; G Piechot; H Jürgens
Journal:  Neurosci Lett       Date:  1990-11-13       Impact factor: 3.046

5.  Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).

Authors:  T Chiba; A Yamaguchi; T Yamatani; A Nakamura; T Morishita; T Inui; M Fukase; T Noda; T Fujita
Journal:  Am J Physiol       Date:  1989-02

6.  Bioactive beta-bend structures for the antagonist halpha CGRP(8 - 37) at the CGRP(1) receptor of the rat pulmonary artery.

Authors:  F M Wisskirchen; P M Doyle; S L Gough; C J Harris; I Marshall
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Biological properties of two models of calcitonin gene related peptide with idealized amphiphilic alpha-helices of different lengths.

Authors:  B Lynch; E T Kaiser
Journal:  Biochemistry       Date:  1988-10-04       Impact factor: 3.162

8.  Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery.

Authors:  M Mimeault; A Fournier; Y Dumont; S St-Pierre; R Quirion
Journal:  J Pharmacol Exp Ther       Date:  1991-09       Impact factor: 4.030

9.  Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis.

Authors:  E E Howell; J E Villafranca; M S Warren; S J Oatley; J Kraut
Journal:  Science       Date:  1986-03-07       Impact factor: 47.728

10.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more
  14 in total

1.  Stable and metastable states of human amylin in solution.

Authors:  Allam S Reddy; Lu Wang; Sadanand Singh; Yun L Ling; Lauren Buchanan; Martin T Zanni; James L Skinner; Juan J de Pablo
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Solution state structures of human pancreatic amylin and pramlintide.

Authors:  John R Cort; Zhihong Liu; Gregory M Lee; K N L Huggins; Susan Janes; Kathryn Prickett; Niels H Andersen
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

3.  Direct detection of transient alpha-helical states in islet amyloid polypeptide.

Authors:  Jessica A Williamson; Andrew D Miranker
Journal:  Protein Sci       Date:  2006-11-22       Impact factor: 6.725

4.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.

Authors:  D L Hay; S G Howitt; A C Conner; M Schindler; D M Smith; D R Poyner
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

Review 5.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

Review 6.  Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Authors:  Silvia Di Angelantonio; Rashid Giniatullin; Valeria Costa; Elena Sokolova; Andrea Nistri
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 7.  Calcitonin gene-related peptide: physiology and pathophysiology.

Authors:  F A Russell; R King; S-J Smillie; X Kodji; S D Brain
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 8.  Structure-activity relationships for α-calcitonin gene-related peptide.

Authors:  Harriet A Watkins; Dan L Rathbone; James Barwell; Debbie L Hay; David R Poyner
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding.

Authors:  Sugato Banerjee; Janel Evanson; Erik Harris; Stephen L Lowe; Kathryn A Thomasson; James E Porter
Journal:  BMC Pharmacol       Date:  2006-06-15

10.  The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.

Authors:  Michael J Woolley; Harriet A Watkins; Bruck Taddese; Z Gamze Karakullukcu; James Barwell; Kevin J Smith; Debbie L Hay; David R Poyner; Christopher A Reynolds; Alex C Conner
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.